1
|
Seo JY, Lee B, Kang TW, Noh JH, Kim MJ, Ji YB, Ju HJ, Min BH, Kim MS. Electrostatically Interactive Injectable Hydrogels for Drug Delivery. Tissue Eng Regen Med 2018; 15:513-520. [PMID: 30603575 PMCID: PMC6171702 DOI: 10.1007/s13770-018-0146-6] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2018] [Revised: 07/03/2018] [Accepted: 07/15/2018] [Indexed: 02/05/2023] Open
Abstract
BACKGROUND Several injectable hydrogels have been developed extensively for a broad range of biomedical applications. Injectable hydrogels forming in situ through the change in external stimuli have the distinct properties of easy management and minimal invasiveness, and thus provide the advantage of bypassing surgical procedures for administration resulting in better patient compliance. METHODS The injectable in situ-forming hydrogels can be formed irreversibly or reversibly under physiological stimuli. Among several external stimuli that induce formation of hydrogels in situ, in this review, we focused on the electrostatic interactions as the most simple and interesting stimulus. RESULTS Currently, numerous polyelectrolytes have been reported as potential electrostatically interactive in situ-forming hydrogels. In this review, a comprehensive overview of the rapidly developing electrostatically interactive in situ-forming hydrogels, which are produced by various anionic and cationic polyelectrolytes such as chitosan, celluloses, and alginates, has been outlined and summarized. Further, their biomedical applications have also been discussed. CONCLUSION The review concludes with perspectives on the future of electrostatically interactive in situ-forming hydrogels.
Collapse
Affiliation(s)
- Ji Young Seo
- Department of Molecular Science and Technology, Ajou University, 206 Worldcup-ro, Yeongton-gu, Suwon, 16499 Republic of Korea
| | - Bong Lee
- Department of Polymer Engineering, Pukyong National University, 45 Yongso-ro, Nam-Gu, Busan, 48513 Republic of Korea
| | - Tae Woong Kang
- Department of Molecular Science and Technology, Ajou University, 206 Worldcup-ro, Yeongton-gu, Suwon, 16499 Republic of Korea
| | - Jung Hyun Noh
- Department of Molecular Science and Technology, Ajou University, 206 Worldcup-ro, Yeongton-gu, Suwon, 16499 Republic of Korea
| | - Min Ju Kim
- Department of Molecular Science and Technology, Ajou University, 206 Worldcup-ro, Yeongton-gu, Suwon, 16499 Republic of Korea
| | - Yun Bae Ji
- Department of Molecular Science and Technology, Ajou University, 206 Worldcup-ro, Yeongton-gu, Suwon, 16499 Republic of Korea
| | - Hyeon Jin Ju
- Department of Molecular Science and Technology, Ajou University, 206 Worldcup-ro, Yeongton-gu, Suwon, 16499 Republic of Korea
| | - Byoung Hyun Min
- Department of Molecular Science and Technology, Ajou University, 206 Worldcup-ro, Yeongton-gu, Suwon, 16499 Republic of Korea
- Cell Therapy Center, Ajou University Medical Center, 206 Worldcup-ro, Yeongton-gu, Suwon, 16499 Republic of Korea
| | - Moon Suk Kim
- Department of Molecular Science and Technology, Ajou University, 206 Worldcup-ro, Yeongton-gu, Suwon, 16499 Republic of Korea
| |
Collapse
|
2
|
Yang HN, Park JS, Jeon SY, Park KH. Carboxymethylcellulose (CMC) formed nanogels with branched poly(ethyleneimine) (bPEI) for inhibition of cytotoxicity in human MSCs as a gene delivery vehicles. Carbohydr Polym 2015; 122:265-75. [DOI: 10.1016/j.carbpol.2014.12.073] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2014] [Revised: 09/13/2014] [Accepted: 12/30/2014] [Indexed: 11/25/2022]
|
3
|
Jakob F, Ebert R, Rudert M, Nöth U, Walles H, Docheva D, Schieker M, Meinel L, Groll J. In situ guided tissue regeneration in musculoskeletal diseases and aging : Implementing pathology into tailored tissue engineering strategies. Cell Tissue Res 2012; 347:725-35. [PMID: 22011785 PMCID: PMC3306563 DOI: 10.1007/s00441-011-1237-z] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2011] [Accepted: 09/01/2011] [Indexed: 12/17/2022]
Abstract
In situ guided tissue regeneration, also addressed as in situ tissue engineering or endogenous regeneration, has a great potential for population-wide "minimal invasive" applications. During the last two decades, tissue engineering has been developed with remarkable in vitro and preclinical success but still the number of applications in clinical routine is extremely small. Moreover, the vision of population-wide applications of ex vivo tissue engineered constructs based on cells, growth and differentiation factors and scaffolds, must probably be deemed unrealistic for economic and regulation-related issues. Hence, the progress made in this respect will be mostly applicable to a fraction of post-traumatic or post-surgery situations such as big tissue defects due to tumor manifestation. Minimally invasive procedures would probably qualify for a broader application and ideally would only require off the shelf standardized products without cells. Such products should mimic the microenvironment of regenerating tissues and make use of the endogenous tissue regeneration capacities. Functionally, the chemotaxis of regenerative cells, their amplification as a transient amplifying pool and their concerted differentiation and remodeling should be addressed. This is especially important because the main target populations for such applications are the elderly and diseased. The quality of regenerative cells is impaired in such organisms and high levels of inhibitors also interfere with regeneration and healing. In metabolic bone diseases like osteoporosis, it is already known that antagonists for inhibitors such as activin and sclerostin enhance bone formation. Implementing such strategies into applications for in situ guided tissue regeneration should greatly enhance the efficacy of tailored procedures in the future.
Collapse
Affiliation(s)
- Franz Jakob
- Orthopedic Center for Musculoskeletal Research, Julius Maximilians University of Wuerzburg, Brettreichstrasse 11, D-97082 Wuerzburg, Germany
| | - Regina Ebert
- Orthopedic Center for Musculoskeletal Research, Julius Maximilians University of Wuerzburg, Brettreichstrasse 11, D-97082 Wuerzburg, Germany
| | - Maximilian Rudert
- Orthopedic Center for Musculoskeletal Research, Julius Maximilians University of Wuerzburg, Brettreichstrasse 11, D-97082 Wuerzburg, Germany
| | - Ulrich Nöth
- Orthopedic Center for Musculoskeletal Research, Julius Maximilians University of Wuerzburg, Brettreichstrasse 11, D-97082 Wuerzburg, Germany
| | - Heike Walles
- Institute for Tissue Engineering and Regenerative Medicine, Julius Maximilians University of Wuerzburg, Röntgenring 11, D-97070 Wuerzburg, Germany
| | - Denitsa Docheva
- Experimental Surgery and Regenerative Medicine, Ludwig Maximilians University Munich, Nußbaumstrasse 20, D-80336 München, Germany
| | - Matthias Schieker
- Experimental Surgery and Regenerative Medicine, Ludwig Maximilians University Munich, Nußbaumstrasse 20, D-80336 München, Germany
| | - Lorenz Meinel
- Chair for Pharmaceutical Technology, Julius Maximilians University of Wuerzburg, Am Hubland, D-97074 Wuerzburg, Germany
| | - Jürgen Groll
- Department and Chair of Functional Materials in Medicine and Dentistry, Julius Maximilians University of Wuerzburg, Pleicherwall 2, D-97070 Wuerzburg, Germany
| |
Collapse
|